PRCT Stock Analysis: Buy, Sell, or Hold?
PRCT - PROCEPT BioRobotics Corporation Common Stock
$19.22
0.02 (0.10%)
▲
5d:
-7.99%
30d:
-13.03%
90d:
-21.62%
HOLD
MODERATE Confidence
Analysis Updated: Jul 17, 2026 12:00 AM ET
Earnings: Aug 05, 2026
17d
Smart Money Accumulation
None View Scanner →
Strength: 3.7/10
Get Alerted When PRCT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PRCT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PRCT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PRCT is currently trading at $19.22, which is considered oversold relative to its 30-day fair value range of $19.41 to $25.21.
Technical Outlook: Technically, PRCT is in a downtrend. Immediate support is located at $17.96, while resistance sits at $21.88.
Market Sentiment: PRCT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $29.30 (+52.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PRCT is in a downtrend. Immediate support is located at $17.96, while resistance sits at $21.88.
Market Sentiment: PRCT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $29.30 (+52.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$19.41 -
$25.21
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 52.4% below Wall St target ($29.30)
- CAUTION: 5-day price weakness (-8.0%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$19.41 -
$25.21
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$17.96
Resistance Level
$21.88
Current Trend
Downtrend
Technical data as of
Jul 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-21.57
Wall Street Target
$29.30
(+52.4%)
Revenue Growth (YoY)
20.2%
Profit Margin
-31.8%
Share & Embed Analysis
Last updated: July 18, 2026 5:25 PM ET
Data refreshes hourly during market hours. Next update: 6:25 PM
Data refreshes hourly during market hours. Next update: 6:25 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRCT showing a specific setup today?
Insider Activity (6 Months)
3
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Alaleh Nouri
SELL
5363 shares
2026-03-19
Alaleh Nouri
SELL
304 shares
2026-03-17
Kevin Waters
SELL
706 shares
2026-03-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 67 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 66 BUY |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$98 | 66 BUY |
